Visualmed – Page 2 – Visual Summaries of Randomized Controlled Trials

ATTR-ACT Trial: Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.

October 9, 2019December 10, 2019 by admin

Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy.

TROPICAL-ACS Trial (2017)

October 9, 2019October 9, 2019 by admin

Guided de-escalation of antiplatelet therapy in patients with ACS undergoing PCI.

TREAT Trial (2019)

October 9, 2019October 9, 2019 by admin

Ticagrelor vs clopidogrel in patients with STEMI treated with fibrinolysis

RAPID-TnT Trial (2009)

October 4, 2019October 9, 2019 by admin

OAT Trial: Coronary Intervention for Persistent Occlusion after MI

October 4, 2019December 10, 2019 by admin

OASIS-5 Trial: Comparison of Fondaparinux and Enoxaparin in ACS

October 4, 2019December 10, 2019 by admin

ISAR-REACT 5 Trial (2019) – Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

October 4, 2019October 4, 2019 by admin

COMFORTABLE-AMI (2014) – Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute MI

October 4, 2019October 4, 2019 by admin

COGENT Trial (2010) – Clopidogrel with or without Omeprazole in Coronary Artery Disease

October 4, 2019October 4, 2019 by admin

VA NEPHRON-D Trial: Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

July 27, 2019July 27, 2019 by admin

The VA NEPHRON-D trial tackled an important question about the combination therapy of ACEi and ARBs. We know from the RENAAL trial that losartan has significant benefits in diabetic nephropathy. The authors of the VA…